UnknownNot Applicable

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

Australia40 participantsStarted 2008-04

Plain-language summary

Data from this study will provide the first information how the innate immune system may be altered in HIV-HCV and HIV-HBV co-infected individuals, and describe Toll-like receptor changes with HIV co-infection therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HIV and either HBV or HCV co-infection * 18 years and older * able to give informed consent Exclusion Criteria: * HIV-HBV-HCV triple infection

What they're measuring

TLR change with HIV co-infection therapy

Timeframe: 6 months

Trial details

NCT IDNCT00662194

SponsorBayside Health

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2014-04

Contact for this trial

Jennifer Audsley, PhD

+613 99030184 jennifer.audsley@med.monash.edu.au

View on ClinicalTrials.gov More HIV-hepatitis Co-infection trials